{
  "ticker": "LLY",
  "target_date": "2025-08-06",
  "actual_date": "2025-08-06",
  "collected_at": "2025-12-08T12:06:30.406972",
  "price": {
    "open": 753.79,
    "high": 760.21,
    "low": 737.48,
    "close": 743.6421508789062,
    "volume": 4752100,
    "change_1d_pct": -2.56,
    "change_7d_pct": -7.64,
    "change_30d_pct": -4.08
  },
  "technicals": {
    "rsi_14": 46.11,
    "sma_20": 774.57,
    "sma_50": 772.85,
    "macd": -5.32,
    "macd_signal": -1.341,
    "macd_histogram": -3.979,
    "bb_upper": 816.31,
    "bb_lower": 732.84,
    "price_vs_sma20_pct": -3.99,
    "price_vs_sma50_pct": -3.78,
    "volume_ratio": 1.29
  },
  "fundamentals": {
    "market_cap": 891553185792,
    "pe_ratio": 48.727585,
    "forward_pe": 43.889233,
    "price_to_book": 37.444656,
    "price_to_sales": 15.004312,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.56,
    "pct_from_52w_low": 59.44
  },
  "macro": {
    "spy": {
      "price": 631.03,
      "change_1d_pct": 0.77,
      "change_7d_pct": -0.39
    },
    "vix": {
      "level": 16.77,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.22
    },
    "dollar_index": {
      "level": 98.18
    },
    "gold": {
      "price": 3380.0
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Janus Henderson Research Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1754523000,
      "summary": "Janus Henderson Research Fund returned 20.45% and the Russell 1000\u00c2\u00ae Growth Index returned 17.84%. Read more here.",
      "url": "https://finnhub.io/api/news?id=8bdafe5707eab551d698d890a4af790f39ae0cab799ae275e30daf9ded83a902"
    },
    {
      "headline": "Eli Lilly Reports Earnings, and Maybe Weight-Loss Pill Data, on Thursday",
      "source": "Yahoo",
      "datetime": 1754512440,
      "summary": "When  Eli Lilly  reports its financial results early Thursday, investors will be looking for the company to press its advantage in the booming weight-loss drug market.  Competitor  Novo Nordisk  has fallen behind Lilly, as Lilly\u2019s weight-loss shot Zepbound has seized a commanding majority of U.S. ob",
      "url": "https://finnhub.io/api/news?id=45221b3e09e5284f7727eea3d374b03be681c9a917f8b2520d67597b2d90dc9b"
    },
    {
      "headline": "Is It Time to Buy Biotech Stocks?",
      "source": "Yahoo",
      "datetime": 1754512080,
      "summary": "A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?",
      "url": "https://finnhub.io/api/news?id=33eac44a9d3205dfed51048f5bc403ac1203a8d1653bbc084ed9691500e72e59"
    },
    {
      "headline": "Cash pay is 'going to constitute a major part of the Wegovy business': Novo Nordisk CFO",
      "source": "Yahoo",
      "datetime": 1754503469,
      "summary": "Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better results.",
      "url": "https://finnhub.io/api/news?id=cdfcc86776946317aea69d5a789399027256f71c00b9f8470101c5a974830dfc"
    },
    {
      "headline": "Eli Lilly Q2 Preview: Can Mounjaro and Zepbound Keep Delivering?",
      "source": "Yahoo",
      "datetime": 1754502817,
      "summary": "Street sees $5.60 EPS on $14.7B revenue as investors weigh drug demand strength.",
      "url": "https://finnhub.io/api/news?id=4d8bc5d675988a37470b0942f6644ef42ddaf2b09480480292a868a4e7ceae95"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-04",
      "description": "xslF345X05/wk-form4_1754338601.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000198/xslF345X05/wk-form4_1754338601.xml"
    },
    {
      "form": "4",
      "date": "2025-07-25",
      "description": "xslF345X05/form4-07252025_040701.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925020284/xslF345X05/form4-07252025_040701.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753219662.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/xslF345X05/wk-form4_1753219662.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753217727.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000194/xslF345X05/wk-form4_1753217727.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753216439.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/xslF345X05/wk-form4_1753216439.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}